I am a practicing radiation oncologist at UPMC/HVHS CancerCenter in Beaver, PA. I remain actively involved in resident and medical student teaching, participating in weekly conferences and facilitating in research endeavors. My research interests include population- and hospital-based registry analyses for evaluation of national practice patterns, advanced brachytherapy techniques for gynecologic malignancies, and quality of life and cost-effectiveness analyses in cancer management.
- Mentorship to rising medical students and radiation oncology residents
- Statistics review course for radiation oncology residents
He S, Gill BS, Heron DE, Kelley JL, Sukumvanich P, Olawaiye AB, Edwards RP, Comerci J, Beriwal S. Long-term outcomes using adjuvant pelvic intensity-modulated radiotherapy (IMRT) for endometrial carcinoma. Pract Radiat Oncol [Epub ahead of press].
Kim H, Gill BS, Beriwal S, Huq MS, Roberts MS, Smith KJ. Cost effectiveness analysis of stereotactic body radiation therapy compared with radiofrequency ablation for inoperable colorectal liver metastases. Int J Radiat Oncol Biol Phys 2016;95(4):1175-1183.
Glaser SM, Mandish SF, Gill BS, Balasubramani GK, Clump DA, Beriwal S. Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival. Head Neck 2016;38(S1):E2083-2090.
Man KX, Gill BS, Balasubramani GK, Sukumvanich P, Kelley JL, Beriwal S. Utilization and role of adjuvant radiotherapy and chemotherapy for uterine clear cell carcinoma: A National Cancer Data Base (NCDB) analysis. Int J Gynecol Cancer 2016;26(3):472-482.
Gill BS, Minkoff DA, Beriwal S. Current concepts in radiation therapy for early stage endometrial cancer. Indian J Gynecol Oncol 2015;13(17).
Gebhardt BJ, Rajagopalan MS, Gill BS, Heron DE, Rakfal SM, Flickinger JC, Beriwal S. The impact of dynamic changes to a bone metastases pathway in a large, integrated National Cancer Institute-Designated Comprehensive Cancer Center Network. Pract Radiat Oncol 2015;5(6):398-405.
Gill BS, Vargo JA, Pai SS, Balasubramani GK, Beriwal S. Management trends and outcomes for stage I-II mantle cell lymphoma using the National Cancer Data Base (NCDB): Ascertaining the ideal treatment paradigm. Int J Radiat Oncol Biol Phys 2015; 93(3):668-676.
Gill BS, Flickinger JC and Beriwal S. The caveat of immortal time bias in adjuvant therapy-related population-based analyses. J Clin Onc 2015; 33(26):2931.
Vargo JA, Gill BS, Balasubramani GK, Beriwal S. Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: Do we still need consolidative radiotherapy?. J Clin Onc 2015; 33(32):3710-3717.
Gill BS, Pai SS, McKenzie S, Beriwal S. Utility of positron emission tomography (PET) for radiotherapy treatment planning. PET Clinics 2015;10(4):541-554.
Vargo JA, Gill BS, Balasubramani GK, Beriwal S. An optimal management of early-stage low-grade follicular lymphoma in the era of rituximab? Cancer 2015;121(18):3325-3334.
Gill BS, Clump DA, Burton SA, Christie NA, Schuchert MJ, Heron DE. Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and I125 vicryl mesh brachytherapy. Front Oncol 2015;11(5):109.
Holt DE, Gill BS, Clump DA, Leeman JE, Burton SA, Engh JA, Amankulor NM, Heron DE. Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally-persistent brain metastasis. Front Oncol 2015;5(84).
Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P, Krivak TC, Olawaiye AB, Kelley JL, Beriwal S. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. Gynecol Oncol 2015;137(3):365-372.
Minkoff D, Gill BS, Kang J, Beriwal S. Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy. Radiother Oncol 2015;115(1):78-83.
Gill BS, Chapman BV, Hansen KJ, Sukumvanich P, Beriwal S. Primary radiotherapy for non-surgically managed stage I endometrial cancer: Utilization and impact of brachytherapy. Brachytherapy 2015;14(3):373-379.
Gill BS, Beriwal S, Rajagopalan MS, Wang H, Hodges K, Greenberger JS. Quantitative evaluation of radiation oncologists’ adaptability to lower reimbursing treatment programs. Pract Radiat Oncol 2015;5(4):267-273.
Gill BS, Kim H, Houser C, Kelley JL, Sukumvanich P, Edwards RP, Comerci JT, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. MRI-guided high dose rate intracavitary brachytherapy for treatment of cervical cancer: The University of Pittsburgh experience. Int J Radiat Oncol Biol Phys 2014;91(3):540-547.
Gill BS and Beriwal S. In regard to Dyk et al. Int J Radiat Oncol Biol Phys 2014;91(4):881-882.
Gill BS, Lin JF, Krivak TC, Sukumvanich P, Laskey RA, Ross MS, Lesnock JL, Beriwal S. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: The impact of new technological advancements. Int J Radiat Oncol Biol Phys 2014;90(5):1083-1090.
Gill BS, Kim H, Houser C, Olsen A, Kelley J, Edwards RP, Comerci J, Sukumvanich P, Olawaiye AB, Huang M, Courtney-Brooks M, Beriwal S. Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma. Brachytherapy 2014;13(6):542-547.
Gabani P, Gill BS, De La Cruz C, Beriwal S. Diffuse chest wall calcifications after post mastectomy radiotherapy for breast cancer. Applied Radiat Oncol 2014.
My ongoing research endeavors include a book chapter reviewing the utility, technique, and side effects of stereotactic radiosurgery for prostate cancer. Other projects include evaluation of practice patterns in the United States for patients with leg-type primary cutaneous B-cell lymphoma, where we utilized the National Cancer Data Base. In this hospital-based registry analysis, patients were infrequently treated with chemotherapy, despite poor outcomes related to a high risk of disease progression. Furthermore,patients receiving chemotherapy had superior survival, suggesting a benefit to selective use in this elderly patient population with this aggressive disease. In a separate project assessing the utility of IMRT for adjuvant endometrial cancer treatment, we analyzed our institutional registry and collected data on outcomes and long-term toxicities. Low rates of toxicity were found among the large cohort of patients with similarly low rates of recurrence, assuaging concerns about conformal treatment leading to higher rates of the latter. A separate analysis was conducted for dosimetry analysis, showing a correlation with higher bone dose and the risk of sacral insufficiency fractures. Both analyses are pending manuscript submission.